<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4083685/" ref="ordinalpos=1792&amp;ncbi_uid=6347575&amp;link_uid=PMC4083685" image-link="/pmc/articles/PMC4083685/figure/F2/" class="imagepopup">Figure 2. 4F treatment down-regulates LPS-mediated expression of genes of the MyD88-dependent and MyD88-independent TLR <span class="highlight" style="background-color:">signaling</span> <span class="highlight" style="background-color:">pathway</span>.  From: Regulation of Pattern Recognition Receptors by the Apolipoprotein A-I Mimetic Peptide 4F. </a></div><br /><div class="p4l_captionBody">MDMs were pre-treated with 4F (white bars) or vehicle (black bars) for 7days and then stimulated with LPS (1µg/ml) for 18hrs. RNA was extracted and transcriptional profiling was carried out using the Affymetrix Human Gene ST1.0 array. Absolute mRNA levels obtained were normalized to unstimulated MDMs, pre-treated with vehicle. Data are means ± SEM (n=4; p&lt;0.05 across all treatments). <b>(A)</b> Effect of LPS on the expression of surface TLRs <b>(B)</b> Effect of LPS on adaptor molecules <b>(C)</b> Effect of LPS on enzymes of the TLR signaling pathway and <b>(D)</b> Effect of LPS on expression of genes of the MyD88-independent pathway. (<b>E</b>) mRNA levels of key genes in the TLR pathway in MDMs pretreated with vehicle (black bars) or 4F (white bars) for 7days and stimulated with LPS (1µg/ml) for 18hrs. The data are normalized to β-actin. Values are means ± SEM (n=4).</div></div>